share_log

Wuhu Token Sciences' (SZSE:300088) Weak Earnings May Only Reveal A Part Of The Whole Picture

Wuhu Token Sciences' (SZSE:300088) Weak Earnings May Only Reveal A Part Of The Whole Picture

蕪湖代幣科學(深圳證券交易所代碼:300088)的疲軟收益可能只能揭示整體情況的一部分
Simply Wall St ·  05/06 19:04

Despite Wuhu Token Sciences Co., Ltd.'s (SZSE:300088) recent earnings report having lackluster headline numbers, the market responded positively. Sometimes, shareholders are willing to ignore soft numbers with the hope that they will improve, but our analysis suggests this is unlikely for Wuhu Token Sciences.

儘管蕪湖代幣科學有限公司's(深圳證券交易所代碼:300088)最近的業績標題數據乏善可陳,市場反應積極。有時,股東願意忽視軟數字,希望它們能有所改善,但我們的分析表明,對於蕪湖代幣科學而言,這不太可能。

earnings-and-revenue-history
SZSE:300088 Earnings and Revenue History May 6th 2024
SZSE: 300088 收益和收入歷史記錄 2024 年 5 月 6 日

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

Importantly, our data indicates that Wuhu Token Sciences' profit received a boost of CN¥81m in unusual items, over the last year. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. Which is hardly surprising, given the name. Wuhu Token Sciences had a rather significant contribution from unusual items relative to its profit to March 2024. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.

重要的是,我們的數據表明,去年蕪湖代幣科學的不尋常項目利潤增加了8100萬元人民幣。雖然我們希望看到利潤增加,但當不尋常的物品做出重大貢獻時,我們往往會更加謹慎一些。當我們計算數千家上市公司的數字時,我們發現,特定年份中不尋常的項目所帶來的提振通常不會在第二年重演。考慮到這個名字,這並不奇怪。截至2024年3月,蕪湖代幣科學從不尋常的項目中獲得了相當大的利潤。在其他條件相同的情況下,這可能會使法定利潤成爲衡量潛在盈利能力的不良指導。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

Our Take On Wuhu Token Sciences' Profit Performance

我們對蕪湖代幣科學盈利表現的看法

As we discussed above, we think the significant positive unusual item makes Wuhu Token Sciences' earnings a poor guide to its underlying profitability. As a result, we think it may well be the case that Wuhu Token Sciences' underlying earnings power is lower than its statutory profit. In further bad news, its earnings per share decreased in the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. So while earnings quality is important, it's equally important to consider the risks facing Wuhu Token Sciences at this point in time. To that end, you should learn about the 3 warning signs we've spotted with Wuhu Token Sciences (including 1 which shouldn't be ignored).

正如我們上面討論的那樣,我們認爲這一重大利好不尋常的項目使蕪湖代幣科學的收益無法衡量其潛在盈利能力。因此,我們認爲蕪湖代幣科學的基礎盈利能力很可能低於其法定利潤。另一個壞消息是,其每股收益在去年有所下降。當然,我們只是在分析其收益時才浮出水面;人們還可以考慮利潤率、預測增長和投資回報率等因素。因此,儘管收益質量很重要,但考慮蕪湖代幣科學目前面臨的風險同樣重要。爲此,你應該了解我們在蕪湖代幣科學發現的3個警告信號(包括一個不容忽視的警告信號)。

This note has only looked at a single factor that sheds light on the nature of Wuhu Token Sciences' profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

這份報告只研究了揭示蕪湖代幣科學利潤性質的單一因素。但是,還有很多其他方法可以讓你對公司的看法。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 “關注資金”,尋找內部人士正在買入的股票。因此,你可能希望看到這份免費收藏的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論